Ailux Appoints Lloyd S. Miller, M.D., Ph.D., as Chief Medical Officer
Dr. Miller will lead the advancement of the company's AI-native biologics toward first-in-human trials, with initial clinical entry targeted for 2027 He will also establish a U.S. clinical and research site to complement the company's research...